Loading data
RMBSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 144.42 m USD | 110.11 m USD | 103.42 m USD | 107.58 m USD | 70.39 m USD |
| Gross profit | 563.22 m USD | 446.52 m USD | 357.7 m USD | 347.21 m USD | 257.91 m USD |
| Research and development expense | 187.71 m USD | 162.88 m USD | 156.83 m USD | 158.77 m USD | 135.68 m USD |
| Selling, general and administrative expense | 115.29 m USD | 104.09 m USD | 108.15 m USD | 106.72 m USD | 91.06 m USD |
| Operating profit | 260.22 m USD | 183.01 m USD | 153.64 m USD | 76.94 m USD | 24.28 m USD |
| Interest expense | — | — | 1.49 m USD | 1.87 m USD | 10.71 m USD |
| Profit before tax | 281.96 m USD | 200.04 m USD | 187.16 m USD | -7.83 m USD | 23.29 m USD |
| Income tax expense | 51.5 m USD | 20.22 m USD | -146.74 m USD | 6.49 m USD | 4.95 m USD |
| Net income (reported basis) | 230.5 m USD | 179.8 m USD | 333.9 m USD | -14.3 m USD | 18.3 m USD |
| Basic earnings per share | 2.14 USD/share | 1.67 USD/share | 3.09 USD/share | -0.13 USD/share | 0.17 USD/share |
| Diluted earnings per share | 2.11 USD/share | 1.65 USD/share | 3.01 USD/share | -0.13 USD/share | 0.16 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.